Researcher Team

Jan Holgersson, MD, PhD


"We are paving the way for the development of mucin-based biopharmaceuticals targeting the vaccine and anti-microbials markets."

Anki Gustafsson, PhD


”My focus is on maximizing the full biomedical potential of carbohydrates.”

Tomas Johansson, PhD


“My primary objective is to establish the foundation for our purification strategies.”

Nathalie Chatzissavidou


”My key responsibility is to develop an effective, robust and scalable fed batch production method for the recombinant mucins. I have simplified the inoculums seed train method and developed a Recopharma proprietary feed composition for the mucine expressing CHO cell lines”